Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.3B | 2.0M | 1.7M | 8.7B |
Cost of revenue | 15.2B | 4.9M | -483K | 8.6B |
Gross profit | 47.7M | -2.9M | 2.2M | 49.3M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.8M | 2.6M | 2.3M | 3.2M |
Operating income | 44.4M | -6.1M | -610K | 45.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | -1.6M | 76K | 2.0M | 32K |
Other income expense | — | — | — | — |
Pretax income | 118.2M | 3.0M | 19.6M | 80.0M |
Tax provision | 7.9M | 1.4M | 200K | 15.9M |
Net income | 110.4M | 1.6M | 19.4M | 64.1M |
Basic EPS | — | 0.1 | 1.4 | 4.7 |
Diluted EPS | — | 0.1 | 1.4 | 4.7 |
Basic average shares | — | 13.5M | 13.7M | 13.6M |
Diluted average shares | — | 13.5M | 13.7M | 13.6M |
EBITDA | 117.2M | 3.6M | 22.1M | 80.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |